CA
NZ
UK
AU
IND
US
…
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for Basel Medical Group Ltd are limited; the company is a Nasdaq-listed healthcare issuer but its filings provide scant operational and financial detail. Because of the restricted information, long-term growth drivers and competitive position cannot be evaluated confidently, although investors may note its healthcare exposure and small-cap liquidity profile.
Primary risks include limited transparency and financial disclosure, low trading liquidity, and material uncertainty around regulatory, operational and execution factors that make assessment of fundamentals difficult.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -12.51M | 2.40M | 2.13M | 2.39M |
| Minority interest | 0.00M | 0.00M | - | - |
| Net income | -12.09M | 2.07M | 1.78M | 1.98M |
| Selling general administrative | 6.54M | 3.64M | 3.27M | 4.04M |
| Gross profit | 8.79M | 7.80M | 7.36M | 8.48M |
| Reconciled depreciation | 1.18M | 0.53M | 0.56M | 0.58M |
| Ebit | -12.30M | 2.58M | 2.37M | 2.71M |
| Ebitda | -11.12M | 3.11M | 2.93M | 3.28M |
| Depreciation and amortization | 1.18M | 0.53M | 0.56M | 0.58M |
| Operating income | -2.18M | 2.20M | 2.00M | 2.47M |
| Other operating expenses | 13.50M | 7.86M | 7.70M | 8.18M |
| Interest expense | 0.20M | 0.18M | 0.24M | 0.32M |
| Tax provision | -0.42M | 0.33M | 0.35M | 0.41M |
| Interest income | 0.08M | 0.00M | 0.30M | 0.25M |
| Net interest income | -0.12M | -0.18M | 0.06M | -0.07M |
| Income tax expense | -0.42M | 0.33M | 0.35M | 0.41M |
| Total revenue | 11.32M | 10.05M | 9.70M | 10.66M |
| Total operating expenses | 10.98M | 5.61M | 5.36M | 6.01M |
| Cost of revenue | 2.53M | 2.25M | 2.34M | 2.18M |
| Total other income expense net | -10.32M | 0.21M | 0.13M | -0.09M |
| Net income from continuing ops | -12.09M | 2.07M | 1.78M | 1.98M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 16.85M | 16.31M | 15.38M | 16.85M |
| Other current assets | 7.27M | 1.71M | 0.13M | 0.15M |
| Total liab | 11.99M | 8.75M | 9.89M | 13.14M |
| Total stockholder equity | 4.86M | 7.56M | 5.49M | 3.71M |
| Other current liab | 6.19M | 3.24M | 1.11M | 1.75M |
| Common stock | 34.21M | 24.46M | 0.00M | 0.00M |
| Capital stock | 34.21M | 24.46M | 0.00M | 0.00M |
| Retained earnings | -4.40M | 7.56M | 5.49M | 3.71M |
| Cash | 2.98M | 1.95M | 1.22M | 1.56M |
| Total current liabilities | 10.69M | 7.16M | 6.47M | 7.19M |
| Net debt | 0.44M | 2.34M | 6.00M | 8.59M |
| Short term debt | 2.12M | 2.71M | 3.79M | 4.20M |
| Short long term debt | 0.06M | 2.68M | 3.22M | 3.63M |
| Short long term debt total | 3.42M | 4.29M | 7.21M | 10.15M |
| Total current assets | 13.12M | 16.17M | 14.77M | 15.67M |
| Long term investments | 0.00M | 0.00M | - | - |
| Net receivables | 2.49M | 12.44M | 13.33M | 13.88M |
| Long term debt | - | 1.58M | 3.40M | 5.31M |
| Inventory | 0.38M | 0.07M | 0.09M | 0.07M |
| Accounts payable | 2.10M | 0.83M | 1.46M | 1.08M |
| Accumulated other comprehensive income | -24.95M | -24.46M | - | - |
| Non current assets total | 3.74M | 0.13M | 0.61M | 1.18M |
| Capital lease obligations | 3.36M | 0.03M | 0.59M | 1.21M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | -11.04M | -0.01M | -0.01M | -0.09M |
| Total cashflows from investing activities | -11.04M | -0.01M | -0.01M | -0.09M |
| Net borrowings | -5.18M | -2.92M | -2.94M | -2.06M |
| Total cash from financing activities | 16.91M | -1.77M | -2.94M | -12.92M |
| Net income | -12.51M | 2.40M | 2.13M | 2.39M |
| Change in cash | 1.03M | 0.73M | -0.35M | -10.22M |
| Begin period cash flow | 1.95M | 1.22M | 1.56M | 11.78M |
| End period cash flow | 2.98M | 1.95M | 1.22M | 1.56M |
| Total cash from operating activities | -4.34M | 2.51M | 2.60M | 2.79M |
| Issuance of capital stock | 9.75M | 0.00M | - | - |
| Depreciation | 1.18M | 0.53M | 0.56M | 0.58M |
| Change to inventory | -0.30M | 0.02M | -0.02M | 0.00M |
| Change to account receivables | -7.28M | -0.42M | 0.54M | 0.01M |
| Other cashflows from financing activities | 12.34M | 1.16M | 0.00M | -10.86M |
| Capital expenditures | 0.05M | 0.01M | 0.01M | 0.09M |
| Change in working capital | -3.25M | -0.00M | 0.29M | 0.08M |
| Other non cash items | 10.23M | -0.42M | -0.38M | -0.25M |
| Free cash flow | -4.40M | 2.50M | 2.59M | 2.70M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BMGL Basel Medical Group Ltd Ordinary Shares |
0.29 6.11% |
5.04 | - | - | 1.03 | 2.51 | 1.38 | 28.65 |
| HCA HCA Healthcare, Inc. |
-4.89 1.02% |
473.19 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
2.68 0.99% |
273.25 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.31 2.36% |
13.35 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.09 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.
| Name | Title | Year Born |
|---|---|---|
| Mr. Keng Leong Fung | Executive Chairman of the Board | 1977 |
| Dr. Yen Feng Chhoa M.D. | Chief Executive Officer | 1988 |
| Ms. Jianing Lu | Group Chief Financial Officer | 1990 |
| Mr. Boon Chye Tan | Chief Commercial Officer & Director | 1981 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...